ArticleReviews in cardiovascular medicine2025
Global Epidemiological Transition of Atrial Fibrillation/Flutter (1990-2021): Multidimensional Burden Dynamics and Socioeconomic Health Gradients Across 204 Countries and Territories.
Article in Reviews in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multimodal Characterization of Atrial Fibrillation: From Patient-Specific Anatomy and Electrophysiology to Standardized Atrial Mapping.Tomography (Ann Arbor, Mich.) · 2026Review
- The present and future of antiarrhythmic drugs.JRSM cardiovascular diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to decode the spatiotemporal trajectory of atrial fibrillation/flutter (AF/AFL) burden (1990-2021) through hierarchical quantification of socioeconomic health gradients and Bayesian projection modeling across 204 countries and territories until 2036. Methods: This study, based on data from the 2021 Global Burden of Disease (GBD) study, systematically investigates the geopolitical and temporal dynamics of AF/AFL from 1990 to 2021. This study quantified the impact of population structure, age distribution, and disease rates on the disease burden, assessed the inequality of burden among different countries, and predicted the disease trends for the next 15 years. Results: From 1990 to 2021, when the age-standardized death rate (ASDR) was the only indicator showing an upward trend (estimated annual percentage change (EAPC) = 0.1 (0.06-0.13)), the absolute number of AF/AFL cases continued to rise. Decomposition analysis revealed that population growth (43.17%) and aging (56.31%) were the primary drivers of the global AF/AFL burden in 2021. The study found that from 1990 to 2021, inequality in the social indicators index (SDI) worsened, whereas the slope index of inequality (SII) values for AF/AFL incidence (41.68 vs. 81.71), prevalence (499.54 vs. 1076.65), mortality (3.23 vs. 8.50), and disability-adjusted life years (DALYs) (82.36 vs. 189.81) all increased. Notably, the global AF/AFL burden is projected to continue rising through 2036. The age-standardized incidence rate (ASIR) (52.36 vs. 56.07) for AF/AFL is expected to increase annually, while the ASDR (4.12 vs. 3.93) and age-standardized DALYs rate (ASDAR) (107.45 vs. 90.87) are projected to decline. However, the number of cases is expected to maintain growth. Conclusions: This study shows that the global burden of AF/AFL has an overall increasing trend from 1990 to 2021, primarily driven by population growth and aging. Countries with a high SDI bear a disproportionately high burden of AF/AFL, while SDI-related inequalities among countries have worsened over time. This study highlights the significant challenges in the prevention and management of AF/AFL, including the rising number of cases and the unequal distribution of the subsequent burden worldwide. These findings may be instructive for developing more effective public health policies and reasonably allocating medical resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.